Benjamin F. Edwards & Company’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $7K | Hold |
3,000
| – | – | ﹤0.01% | 1814 |
|
|
2024
Q1 | $7K | Hold |
3,000
| – | – | ﹤0.01% | 1800 |
|
|
2023
Q4 | $7K | Hold |
3,000
| – | – | ﹤0.01% | 1787 |
|
|
2023
Q3 | $6K | Hold |
3,000
| – | – | ﹤0.01% | 1534 |
|
|
2023
Q2 | $8K | Hold |
3,000
| – | – | ﹤0.01% | 1464 |
|
|
2023
Q1 | $5K | Hold |
3,000
| – | – | ﹤0.01% | 1561 |
|
|
2022
Q4 | $4K | Hold |
3,000
| – | – | ﹤0.01% | 1639 |
|
|
2022
Q3 | $5K | Hold |
3,000
| – | – | ﹤0.01% | 1572 |
|
|
2022
Q2 | $5K | Hold |
3,000
| – | – | ﹤0.01% | 1558 |
|
|
2022
Q1 | $8K | Hold |
3,000
| – | – | ﹤0.01% | 1436 |
|
|
2021
Q4 | $9K | Hold |
3,000
| – | – | ﹤0.01% | 1416 |
|
|
2021
Q3 | $7K | Hold |
3,000
| – | – | ﹤0.01% | 1468 |
|
|
2021
Q2 | $12K | Buy |
+3,000
| New | +$12K | ﹤0.01% | 1352 |
|